Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of GENOSS PCB (Paclitaxel-coated Balloon) in Patients With Long Femoropopliteal Lesion: A Prospective, Multicenter, Observational Study (GENOSS-PCB Long)

NCT07425171 is registered in ClinicalTrials.gov with Genoss Co., Ltd. as lead sponsor.

NCT NCT07425171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07425171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of GENOSS PCB (Paclitaxel-coated Balloon) in Patients With Long Femoropopliteal Lesion: A Prospective, Multicenter, Observational Study (GENOSS-PCB Long)
Lead sponsor
Genoss Co., Ltd.
Phase
Observational
Overall status
Recruiting
Start date
April 13, 2026
Completion date
December 31, 2028
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

femoropopliteal artery disease, long femoropopliteal artery disease, pta (percutaneous transluminal angioplasty)